Skip to main content

Find Clinical Trials

Home
Conditions
Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer

Clinical trial condition

Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer

Explore clinical trials studying Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer trial results

Active, Not Recruiting

Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.

NCT07274761

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China

View Trial Details